110 related articles for article (PubMed ID: 15781238)
1. Loss of lysophospholipase 3 increases atherosclerosis in apolipoprotein E-deficient mice.
Taniyama Y; Fuse H; Satomi T; Tozawa R; Yasuhara Y; Shimakawa K; Shibata S; Hattori M; Nakata M; Taketomi S
Biochem Biophys Res Commun; 2005 Apr; 330(1):104-10. PubMed ID: 15781238
[TBL] [Abstract][Full Text] [Related]
2. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.
Shiraishi Y; Watanabe T; Suguro T; Nagashima M; Kato R; Hongo S; Itabe H; Miyazaki A; Hirano T; Adachi M
J Hypertens; 2008 Oct; 26(10):1955-65. PubMed ID: 18806619
[TBL] [Abstract][Full Text] [Related]
3. Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice.
She ZG; Zheng W; Wei YS; Chen HZ; Wang AB; Li HL; Liu G; Zhang R; Liu JJ; Stallcup WB; Zhou Z; Liu DP; Liang CC
Circ Res; 2009 May; 104(10):1160-8. PubMed ID: 19359600
[TBL] [Abstract][Full Text] [Related]
4. Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis.
Merched AJ; Chan L
Circulation; 2004 Dec; 110(25):3830-41. PubMed ID: 15596565
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
Raffai RL; Loeb SM; Weisgraber KH
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice.
Inoue K; Arai Y; Kurihara H; Kita T; Sawamura T
Circ Res; 2005 Jul; 97(2):176-84. PubMed ID: 15961718
[TBL] [Abstract][Full Text] [Related]
7. Oxidized monocyte-derived macrophages in aortic atherosclerotic lesion from apolipoprotein E-deficient mice and from human carotid artery contain lipid peroxides and oxysterols.
Maor I; Kaplan M; Hayek T; Vaya J; Hoffman A; Aviram M
Biochem Biophys Res Commun; 2000 Mar; 269(3):775-80. PubMed ID: 10720491
[TBL] [Abstract][Full Text] [Related]
8. Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide.
Recalde D; Ostos MA; Badell E; Garcia-Otin AL; Pidoux J; Castro G; Zakin MM; Scott-Algara D
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):756-61. PubMed ID: 14751811
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
[TBL] [Abstract][Full Text] [Related]
10. Genetic ablation of caveolin-1 confers protection against atherosclerosis.
Frank PG; Lee H; Park DS; Tandon NN; Scherer PE; Lisanti MP
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):98-105. PubMed ID: 14563650
[TBL] [Abstract][Full Text] [Related]
11. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
Kitayama K; Nishizawa T; Abe K; Wakabayashi K; Oda T; Inaba T; Amemiya Y
J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
[TBL] [Abstract][Full Text] [Related]
12. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
13. Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage.
Li K; Yao W; Zheng X; Liao K
Cell Res; 2009 Aug; 19(8):1006-17. PubMed ID: 19546885
[TBL] [Abstract][Full Text] [Related]
14. Determination of atherogenesis in apolipoprotein E-knockout mice.
Napoli C; Palinski W; Di Minno G; D'Armiento FP
Nutr Metab Cardiovasc Dis; 2000 Aug; 10(4):209-15. PubMed ID: 11079259
[TBL] [Abstract][Full Text] [Related]
15. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
[TBL] [Abstract][Full Text] [Related]
16. Effect of asymmetric dimethylarginine on atherogenesis and erythrocyte deformability in apolipoprotein E deficient mice.
Xiao HB; Yang ZC; Jia SJ; Li NS; Jiang DJ; Zhang XH; Guo R; Zhou Z; Deng HW; Li YJ
Life Sci; 2007 Jun; 81(1):1-7. PubMed ID: 17532008
[TBL] [Abstract][Full Text] [Related]
17. Hepatic lipase expression in macrophages contributes to atherosclerosis in apoE-deficient and LCAT-transgenic mice.
Nong Z; Gonzalez-Navarro H; Amar M; Freeman L; Knapper C; Neufeld EB; Paigen BJ; Hoyt RF; Fruchart-Najib J; Santamarina-Fojo S
J Clin Invest; 2003 Aug; 112(3):367-78. PubMed ID: 12897204
[TBL] [Abstract][Full Text] [Related]
18. Disruption of hedgehog signalling in ApoE - /- mice reduces plasma lipid levels, but increases atherosclerosis due to enhanced lipid uptake by macrophages.
Beckers L; Heeneman S; Wang L; Burkly LC; Rousch MM; Davidson NO; Gijbels MJ; de Winther MP; Daemen MJ; Lutgens E
J Pathol; 2007 Aug; 212(4):420-8. PubMed ID: 17573667
[TBL] [Abstract][Full Text] [Related]
19. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice.
Daugherty A; Puré E; Delfel-Butteiger D; Chen S; Leferovich J; Roselaar SE; Rader DJ
J Clin Invest; 1997 Sep; 100(6):1575-80. PubMed ID: 9294126
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-1 deficiency in bone marrow cells increases early atherosclerosis in apolipoprotein E- and low-density lipoprotein receptor-null mice.
Babaev VR; Ding L; Reese J; Morrow JD; Breyer MD; Dey SK; Fazio S; Linton MF
Circulation; 2006 Jan; 113(1):108-17. PubMed ID: 16380543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
